In mouse models of colon carcinoma, IL-6 and GM-CSF secreted by CAFs drive monocyte differentiation toward M2-like TAMs [348], whereas CXCL13 recruits lymphotoxin-expressing B cells to increase prostate cancer aggressiveness [337, 339]. Here, CXCL13 is linked to prostate cancer.